Clinical trial
Ultravist: Safety and Efficacy in Computed Tomography of Head and Body
NCT00244140 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00244140 |
|---|---|
| Title | Ultravist: Safety and Efficacy in Computed Tomography of Head and Body |
| Official title | Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL): Safety and Efficacy in Computed Tomography of Head and Body |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Computed Tomography, Diagnostic Imaging |
| Intervention type | Drug |
| Interventions | Iopromide 370 mg I/mL, Iopromide 300 mg I/mL |
| Enrollment | 435 |
| Start date | Oct 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Oct 26, 2005 |
| Last update posted | Feb 28, 2014 |
| Countries | Colombia, India, South Korea, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: